From: The effect of radioiodine treatment on the characteristics of TRAb in Graves’ disease
GD patients with decreased antibodies | GD patients with increased antibodies | GD patients with unchanged antibodies | ||||
---|---|---|---|---|---|---|
TRAb*** | TPOAb### | TRAb | TPOAb | TRAb | TPOAb | |
1-6 m | 18% (4/22) | 0 (0/22) | 73% (16/22) | 27% (6/22) | 9% (2/22) | 73% (16/22) |
7-12 m | 36% (10/28) | 7% (2/28) | 53% (15/28) | 29% (8/28) | 11% (3/28) | 64% (18/28) |
13-60 m | 79% (83/105) | 38% (40/105) | 19% (20/105) | 15% (16/105) | 2% (2/105) | 47% (49/105) |
>60 m | 88% (42/48) | 65% (31/48) | 2% (1/48) | 12% (6/48) | 10% (5/48) | 23% (11/48) |